Trial Profile
Budenofalk granules and capsules in the treatment of active Crohn's disease - a prospective, multicenter, observational study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2016
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms BALANCE
- Sponsors Dr Falk Pharma
- 04 Oct 2016 New trial record